Akumin Inc. – NASDAQ:AKU

Financial Health
0
1
2
3
4
5
6
7
8
9

Akumin stock price monthly change

+104.97%
month

Akumin stock price quarterly change

+5.09%
quarter

Akumin stock price yearly change

-84.79%
year

Akumin key metrics

Market Cap
26.27M
Enterprise value
1.45B
P/E
-0.34
EV/Sales
1.94
EV/EBITDA
21.50
Price/Sales
0.05
Price/Book
-0.81
PEG ratio
N/A
EPS
-2.65
Revenue
743.67M
EBITDA
127.37M
Income
-224.91M
Revenue Q/Q
-3.79%
Revenue Y/Y
11.66%
Profit margin
-20.91%
Oper. margin
4.91%
Gross margin
18.53%
EBIT margin
4.91%
EBITDA margin
17.13%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Akumin stock price history

Akumin stock forecast

Akumin financial statements

Akumin Inc. (NASDAQ:AKU): Profit margin
Sep 2022 186.60M -49.74M -26.66%
Dec 2022 184.63M -49.33M -26.72%
Mar 2023 187.59M -29.19M -15.56%
Jun 2023 184.84M -96.65M -52.29%
Akumin Inc. (NASDAQ:AKU): Earnings per share (EPS)
2023-03-16 -0.17 -0.17
Akumin Inc. (NASDAQ:AKU): Debt to assets
Sep 2022 1809238000 1.61B 89.11%
Dec 2022 1765115000 1.62B 92%
Mar 2023 1722673000 1.61B 93.97%
Jun 2023 1635742000 1.63B 99.97%
Akumin Inc. (NASDAQ:AKU): Cash Flow
Sep 2022 34.85M -17.12M 3.17M
Dec 2022 9.43M -7.07M -2.28M
Mar 2023 3.30M -2.18M -15.14M
Jun 2023 14.65M -8.45M -13.62M

Akumin alternative data

Akumin Inc. (NASDAQ:AKU): Employee count
Aug 2023 1,737
Sep 2023 1,737
Oct 2023 1,737
Nov 2023 1,737
Dec 2023 1,737
Jan 2024 1,737
Feb 2024 1,737
Mar 2024 1,737
Apr 2024 1,737
May 2024 1,737
Jun 2024 1,737
Jul 2024 1,737

Akumin other data

1.46% -14.25%
of AKU is owned by hedge funds
1.30M -12.76M
shares is hold by hedge funds

Akumin Inc. (NASDAQ:AKU): Insider trades (number of shares)
Period Buy Sel
Jan 2022 75000 75000
Mar 2022 0 20304
Jul 2022 3065257 3065257
Aug 2022 57838 0
Transaction Date Insider Security Shares Price per share Total value Source
Option
DAVIES THOMAS director
Stock Option (right to buy) 150,000 $0.5 $75,000
Option
DAVIES THOMAS director
Common Stock 150,000 $0.5 $75,000
Purchase
KRETSCHMER R. DAVID officer: Interim Chief Financia..
Common Stock 5,338 $1.33 $7,094
Purchase
KRETSCHMER R. DAVID officer: Interim Chief Financia..
Common Stock 6,500 $1.38 $8,957
Purchase
KRETSCHMER R. DAVID officer: Interim Chief Financia..
Common Stock 2,500 $1.07 $2,675
Purchase
KRETSCHMER R. DAVID officer: Interim Chief Financia..
Common Stock 2,500 $1.09 $2,725
Purchase
KRETSCHMER R. DAVID officer: Interim Chief Financia..
Common Stock 5,000 $1.16 $5,800
Purchase
KRETSCHMER R. DAVID officer: Interim Chief Financia..
Common Stock 10,000 $1.14 $11,400
Purchase
LEE MURRAY director
Common Stock 1,000 $1.43 $1,430
Purchase
LEE MURRAY director
Common Stock 400 $1.14 $456
Insider Compensation
Mr. Riadh Zine-El-Abidine (1972) Chairman & Co-Chief Executive Officer
$1,260,000
Monday, 23 October 2023
InvestorPlace
Saturday, 12 August 2023
Seeking Alpha
Thursday, 6 July 2023
InvestorPlace
Sunday, 14 May 2023
Seeking Alpha
Friday, 10 March 2023
PRNewsWire
Saturday, 12 November 2022
Seeking Alpha
Wednesday, 10 August 2022
Seeking Alpha
Thursday, 4 August 2022
PRNewsWire
Friday, 13 May 2022
Seeking Alpha
Wednesday, 6 April 2022
Zacks Investment Research
Monday, 4 April 2022
Zacks Investment Research
Monday, 21 March 2022
Zacks Investment Research
Tuesday, 11 January 2022
PRNewsWire
Monday, 18 October 2021
Newsfile Corp
Friday, 15 October 2021
Newsfile Corp
Monday, 11 October 2021
Newsfile Corp
Sunday, 10 October 2021
Newsfile Corp
Thursday, 7 October 2021
Newsfile Corp
Sunday, 3 October 2021
Newsfile Corp
Sunday, 26 September 2021
Newsfile Corp
Thursday, 23 September 2021
Newsfile Corp
Wednesday, 22 September 2021
Newsfile Corp
Monday, 20 September 2021
Newsfile Corp
Sunday, 19 September 2021
Newsfile Corp
Monday, 13 September 2021
Newsfile Corp
Sunday, 12 September 2021
Newsfile Corp
Friday, 10 September 2021
Newsfile Corp
Thursday, 9 September 2021
Newsfile Corp
Sunday, 5 September 2021
Newsfile Corp
Sunday, 29 August 2021
Newsfile Corp
  • When is Akumin's next earnings date?

    Unfortunately, Akumin's (AKU) next earnings date is currently unknown.

  • Does Akumin pay dividends?

    No, Akumin does not pay dividends.

  • How much money does Akumin make?

    Akumin has a market capitalization of 26.27M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 78.03% to 749.63M US dollars. Akumin made a loss 151.59M US dollars in net income (profit) last year or -$0.17 on an earnings per share basis.

  • What is Akumin's stock symbol?

    Akumin Inc. is traded on the NASDAQ under the ticker symbol "AKU".

  • What is Akumin's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of Akumin?

    Shares of Akumin can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Akumin's key executives?

    Akumin's management team includes the following people:

    • Mr. Riadh Zine-El-Abidine Chairman & Co-Chief Executive Officer(age: 53, pay: $1,260,000)
  • How many employees does Akumin have?

    As Jul 2024, Akumin employs 1,737 workers.

  • When Akumin went public?

    Akumin Inc. is publicly traded company for more then 5 years since IPO on 3 Sep 2020.

  • What is Akumin's official website?

    The official website for Akumin is akumin.com.

  • Where are Akumin's headquarters?

    Akumin is headquartered at 8300 West Sunrise Boulevard, Plantation, FL.

  • How can i contact Akumin?

    Akumin's mailing address is 8300 West Sunrise Boulevard, Plantation, FL and company can be reached via phone at +95 45 776 000.

Akumin company profile:

Akumin Inc.

akumin.com
Exchange:

NASDAQ

Full time employees:

1,737

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures through a network of approximately 200 owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to approximately 1,000 hospitals and health systems across 46 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.

8300 West Sunrise Boulevard
Plantation, FL 33322

CIK: 0001776197
ISIN: CA01021F1099
CUSIP: 01021F109